Dr. Johannes Heverhagen, PhD[email protected]Clinical NewsLearn from NSF crisis to avoid 'gadolinium phobia'When the nephrogenic systemic fibrosis (NSF) crisis broke out, very effective countermeasures were drawn up and implemented. In the current debate over the safety of gadolinium-based MRI contrast agents, we must learn three vital lessons from the NSF episode and bear them in mind, Dr. Johannes Heverhagen, PhD, said.March 21, 2016Page 1 of 1Top StoriesMRISiemens begins construction on DryCool facility, MRI magnet plantThe new facility is one of six current and planned Siemens Healthineers manufacturing sites in the U.K., according to Siemens.CTAI stroke software differences don't affect thrombectomy eligibilityUltrasoundSamsung Medison to acquire SonioWomens ImagingHologic brings Brevera 7-gauge breast biopsy needle to EuropeSponsor ContentJourney to the Cloud: A Snapshot of Market Progress - 22 May @ 7pm CET